It is worthwhile studying common variation in the ATM, CHEK2 and ERBB2 genes in relation to breast cancer progression because defects in the genes could increase the risk of developing tumours with an unfavourable prognosis through their role in the regulation of cell cycle checkpoints and amplification. Here, ERBB2 is linked to neoplasm.